Literature DB >> 20832519

Risk factors for delayed graft function after hand-assisted laparoscopic donor nephrectomy.

R C Minnee1, W A Bemelman, K A M I Donselaar-van der Pant, J Booij, S ter Meulen, I J M ten Berge, D A Legemate, F J Bemelman, M M Idu.   

Abstract

BACKGROUND: Delayed graft function (DGF) has a negative effect on the results of living-donor kidney transplantation.
OBJECTIVE: To investigate potential risk factors for DGF.
METHODS: This prospective study included 200 consecutive living donors and their recipients between January 2002 and July 2007. Delayed graft function was defined as need for dialysis within the first postoperative week.
RESULTS: Delayed graft function was diagnosed in 12 patients (6%). Intraoperative complications occurred in 10 donors (5%), and postoperative complications in 24 donors (13.5%). One-year kidney graft survival with vs without DGF was 52% and 98%, respectively (P < .002). In donors, 2 univariate risk factors for DGF identified were lower counts per second at peak activity during scintigraphy, and multiple renal veins. In recipients, only 2 or more kidney transplantations and occurrence of an acute rejection episode were important factors. At multivariate analysis, increased risk of DGF was associated with the presence of multiple renal veins (odds ratio, 151.57; 95% confidence interval, 2.53-9093.86) and an acute rejection episode (odds ratio, 78.87; 95% confidence interval, 3.17-1959.62).
CONCLUSION: Hand-assisted laparoscopic donor nephrectomy is a safe procedure. The presence of multiple renal veins and occurrence of an acute rejection episode are independent risk factors for DGF. 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20832519     DOI: 10.1016/j.transproceed.2010.05.163

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


  1 in total

1.  Hand-assisted living-donor nephrectomy: a retrospective comparison of two techniques.

Authors:  Jeannette D Widmer; Andrea Schlegel; Philipp Kron; Marc Schiesser; Jens G Brockmann; Markus K Muller
Journal:  BMC Urol       Date:  2018-05-10       Impact factor: 2.264

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.